Darmstadt, Germany

Reinhard Lissner


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Darmstadt, DE (1978 - 1980)
  • Fischbachtal- Lichtenberg, DE (1981)

Company Filing History:


Years Active: 1978-1981

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Reinhard Lissner: Innovator in Pharmacological Compounds

Introduction

Reinhard Lissner is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that exhibit lipid-lowering and anti-thrombotic properties. With a total of 9 patents to his name, Lissner's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Lissner has developed lipid-lowering and anti-thrombotic 6-arylpyridazin-3-ones. These compounds are characterized by a specific formula where R¹ can be 4-biphenylyl or 4-phenoxyphenyl, with various substitutions. Additionally, he has worked on new prostaglandin-like diketals, which include their mirror images and racemic mixtures, along with physiologically acceptable salts. These innovations possess valuable pharmacological properties, such as lowering lipid levels and providing anti-thrombotic effects.

Career Highlights

Lissner is associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he has been instrumental in advancing research and development in pharmacological compounds. His expertise and innovative approach have led to the creation of several important patents that contribute to the medical field.

Collaborations

Lissner has collaborated with notable colleagues, including Dieter Orth and Hans-Eckart Radunz. Their combined efforts have fostered a productive environment for innovation and research.

Conclusion

Reinhard Lissner's contributions to pharmacology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of important medical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…